Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2
Closed -$16 7548
2024
Q1
$16 Hold
2
﹤0.01% 7184
2023
Q4
$17 Hold
2
﹤0.01% 7266
2023
Q3
$16 Hold
2
﹤0.01% 7281
2023
Q2
$24 Buy
2
+1
+100% +$26 ﹤0.01% 7271
2023
Q1
$56 Hold
1
﹤0.01% 7083
2022
Q4
$62 Hold
1
﹤0.01% 6940
2022
Q3
$0 Hold
1
﹤0.01% 7494
2022
Q2
$0 Hold
1
﹤0.01% 7626
2022
Q1
$0 Sell
1
-185
-99% -$62.5K ﹤0.01% 7949
2021
Q4
$72K Buy
186
+93
+100% +$54.1K ﹤0.01% 5796
2021
Q3
$70K Buy
93
+50
+116% +$41.8K ﹤0.01% 5517
2021
Q2
$45K Buy
43
+42
+4,200% +$50.2K ﹤0.01% 5600
2021
Q1
$1K Hold
1
﹤0.01% 6778
2020
Q4
$1K Hold
1
﹤0.01% 6389
2020
Q3
$0 Sell
1
-1
-50% -$954 ﹤0.01% 7003
2020
Q2
$2K Sell
2
-62
-97% -$27.8K ﹤0.01% 6117
2020
Q1
$22K Hold
64
﹤0.01% 5578
2019
Q4
$52K Hold
64
﹤0.01% 5503
2019
Q3
$91K Buy
64
+62
+3,100% +$99.4K ﹤0.01% 5361
2019
Q2
$3K Buy
2
+1
+100% +$2.03K ﹤0.01% 6132
2019
Q1
$2K Buy
+1
New +$1.57K ﹤0.01% 5883

Other funds holding YCBD

Wells Fargo's YCBD Position: Q2 2024 in Review

Wells Fargo sold out of cbdMD (YCBD) in Q2 2024, closing a stake of 2 shares — an estimated $16 sold.

Wells Fargo first reported a position in YCBD in Q1 2019 and held it in 21 quarters. The position peaked at $91K in Q3 2019. 19 funds tracked by Wall St. Rank hold YCBD as of Q2 2024.

  • Wells Fargo reported no remaining cbdMD position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 2 cbdMD shares in Q2 2024, an estimated $16.
  • Wells Fargo first reported a position in cbdMD in Q1 2019 and held it in 21 quarters.
  • Wells Fargo's cbdMD position peaked at $91K in Q3 2019.
  • 19 funds tracked by Wall St. Rank held cbdMD as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.